CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chochinov, M.
Right arrow Articles by Halpern, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chochinov, M.
Right arrow Articles by Halpern, S.
Canadian Journal of Anesthesia 49:A9 (2002)
© Canadian Anesthesiologists' Society, 2002


Abstracts - Monday June 24th 2002 1030 - 1200

{alpha}–1 AGONISTS VS EPHEDRINE FOR C/S HYPOTENSION: A SYSTEMATIC REVIEW

Michelle Chochinov, MD and Stephen Halpern, MD

From the Department of Anaesthesia, Sunnybrook and Women's Health Sciences Centre, 76 Grenville St. Toronto, Ontario M5S 1B2

INTRODUCTION

Because {alpha}-1 agonists have been shown to have deleterious effects on uterine blood flow in animals, ephedrine has become the vasopressor of choice in the hypotensive obstetric patient. We report a systematic review of human studies to determine if {alpha}-1 agonists cause harm to the neonate.

METHODS

We searched Medline, Embase, and the Cochrane Database from 1966 to present. Key words used were phenylephrine, ephedrine, pregnancy and cesarean section. We also hand searched appropriate journals and supplements for the last 5yrs. We excluded non-human studies. We included any study comparing ephedrine to an {alpha}-1 agonist to treat or prevent hypotension due to neuroaxial blockade for elective cesarean section in full term parturients. All RCT=s were rated using a validated 5 point scoring system, with a score of >= 3 being high quality. Two independent investigators completed searching and scoring. The primary outcome was UApH. The secondary outcome were neonatal Apgar scores. Because of heterogeneous methodology, we did not combine the results mathematically, rather we used a graphical display.

RESULTS

We found 13 studies comprised of 737 patients that met our inclusion criteria. 12/13 RCTs–9 were of high quality. {alpha}-1 agonists used included phenylephrine in 10 studies, angiotensin II in 2, and metaraminol in 1. 7 studies used prophylactic vasopressor, 5 used only rescue doses, and 1 study included either. 5 studies showed no significant difference in UApH between groups (one compared UV pH, with no significant difference). 8 studies showed significantly better UA pHs in the {alpha}-1 agonist group (FigureGo). There were no significant differences in Apgar scores.



View larger version (12K):
[in this window]
[in a new window]
 
L'Abbe Plot of Cord pH––Ephedrine VS Alpha-1 Agonists

 
DISCUSSION

Animal studies have shown ephedrine to be better for the fetus than {alpha}-1 agonists. This systematic review of human studies has shown {alpha}-1 agonists to be equally as safe or better than ephedrine. The use of {alpha}-1 agonists in obstetric patients deserves further investigation.

REFERENCES

Available from MC.





This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chochinov, M.
Right arrow Articles by Halpern, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chochinov, M.
Right arrow Articles by Halpern, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS